Companies in #Cardiology

Alembic Pharmaceuticals is an Indian multinational pharmaceutical company focused on the development, manufacturing, and commercialization of generic pharmaceutical products. Recently received an FDA warning letter on its bioequivalence site over informed consent concerns.

Bayer (ETR: BAYN) is a diversified life sciences company headquartered in Leverkusen, Germany.

Capricor Therapeutics (NASDAQ: CAPR) is a cell therapy company headquartered in Beverly Hills, California, USA.

Clinical-stage biotechnology company developing pre-hospital therapies for heart attacks, led by zalunfiban (RUC-4), an investigational subcutaneous GPIIb/IIIa platelet inhibitor designed for first-medical-contact treatment of STEMI.

Connected medical device company developing the NORM system, an implantable inferior vena cava sensor plus wearable reader that measures fluid volume directly to guide at-home heart failure management.

Ionis Pharmaceuticals is a leader in RNA-targeted therapeutics, discovering and developing antisense oligonucleotide (ASO) drugs for serious diseases.

Osanni Bio is a San Francisco-based biotechnology company building a pipeline of therapeutics for ophthalmology and cardiology indications. The company raised $190M in 2026 to advance its portfolio of small-molecule and biologic candidates addressing high-prevalence vision and cardiovascular diseases.

Tempus AI is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. Its platform collects and analyzes clinical and molecular data to enable physicians and researchers to make data-driven decisions in oncology, cardiology, and other disease areas.